tradingkey.logo
tradingkey.logo
Search

Assembly Biosciences Inc

ASMB
Add to Watchlist
25.110USD
-0.950-3.65%
Close 07-31 16:00ETQuotes delayed by 15 min
497.60MMarket Cap
274.55P/E TTM

ASMB Financials

See Assembly Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Assembly Biosciences Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.54/-0.57
Revenue / Forecast
8.21M/9.27M
Period
FY2025 Earnings
Revenue(YoY)
72.30M
153.52%
EPS(YoY)
-0.55
91.84%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
54.27%-0.54
182.46%1.30
52.11%-0.72
32.60%-1.33
29.04%-1.17
33.96%-1.58
54.02%-1.51
49.06%-1.98
62.86%-1.66
56.54%-2.39
---3.29
---3.88
---4.46
---5.51
---17.57
----
----
----
----
----
Revenue
-12.80%8.21M
477.26%42.47M
57.62%10.79M
12.81%9.63M
62.82%9.42M
2.71%7.36M
--6.84M
--8.53M
--5.79M
--7.16M
----
----
----
--0.00
-100.00%0.00
----
----
-100.00%0.00
-81.93%6.25M
-100.00%0.00
Net Profit
-2.96%-9.08M
313.74%22.09M
4.34%-9.20M
8.55%-10.20M
2.85%-8.82M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
51.05%-10.96M
37.70%-14.42M
30.93%-16.90M
17.93%-18.95M
62.83%-22.39M
-23.09%-23.14M
-3.67%-24.46M
15.11%-23.09M
-52.87%-60.26M
-461.45%-18.80M
-424.55%-23.59M
Net Margin
-18.08%-110.54%
137.03%52.01%
39.31%-85.23%
18.94%-105.94%
40.33%-93.62%
8.21%-140.48%
---140.44%
---130.69%
---156.91%
---153.04%
----
----
----
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
Revenue
-12.80%8.21M
477.26%42.47M
57.62%10.79M
12.81%9.63M
62.82%9.42M
2.71%7.36M
--6.84M
--8.53M
--5.79M
--7.16M
----
----
----
--0.00
-100.00%0.00
----
----
-100.00%0.00
-81.93%6.25M
-100.00%0.00
Operating profit
-14.37%-11.37M
271.69%19.80M
0.67%-10.88M
9.10%-11.09M
7.34%-9.94M
8.12%-11.53M
27.19%-10.96M
30.22%-12.20M
45.15%-10.73M
46.92%-12.55M
33.47%-15.05M
25.81%-17.49M
15.56%-19.56M
-11.27%-23.65M
-19.83%-22.62M
1.62%-23.57M
18.18%-23.16M
37.42%-21.25M
-369.64%-18.88M
-464.22%-23.96M
Net Profit
-2.96%-9.08M
313.74%22.09M
4.34%-9.20M
8.55%-10.20M
2.85%-8.82M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
51.05%-10.96M
37.70%-14.42M
30.93%-16.90M
17.93%-18.95M
62.83%-22.39M
-23.09%-23.14M
-3.67%-24.46M
15.11%-23.09M
-52.87%-60.26M
-461.45%-18.80M
-424.55%-23.59M
Current assets
143.50%232.61M
120.38%254.55M
141.12%236.81M
-31.40%77.47M
-18.47%95.53M
-13.67%115.50M
97.72%98.21M
76.23%112.93M
46.93%117.17M
37.97%133.79M
-56.84%49.67M
-48.44%64.08M
-39.02%79.74M
-37.12%96.97M
-38.86%115.08M
-39.53%124.29M
-40.99%130.78M
-31.31%154.20M
-23.61%188.22M
-12.56%205.56M
Total current liabilities
-24.95%35.00M
2.04%48.78M
28.21%53.38M
14.58%47.29M
20.33%46.63M
21.87%47.80M
483.78%41.63M
367.38%41.27M
288.70%38.75M
140.70%39.23M
-53.87%7.13M
-40.97%8.83M
-6.90%9.97M
1.39%16.30M
3.57%15.46M
7.56%14.96M
-26.13%10.71M
-34.22%16.07M
-11.16%14.93M
-19.46%13.91M
Total assets
137.85%235.51M
116.16%257.59M
139.37%240.00M
-29.95%80.78M
-17.41%99.02M
-12.90%119.17M
94.20%100.26M
73.22%115.32M
44.24%119.88M
34.41%136.82M
-57.51%51.63M
-53.59%66.58M
-48.92%83.12M
-46.72%101.79M
-51.19%121.52M
-45.28%143.45M
-41.65%162.73M
-32.55%191.06M
-18.72%248.97M
-11.08%262.14M
Total liabilities
-48.67%36.90M
-40.75%50.84M
-22.83%57.30M
-22.27%62.68M
-17.64%71.88M
-10.36%85.81M
648.96%74.26M
593.51%80.64M
582.80%87.28M
400.40%95.73M
-48.12%9.91M
-40.27%11.63M
-19.80%12.78M
-13.56%19.13M
-21.44%19.11M
-35.84%19.47M
-49.65%15.94M
-48.14%22.13M
-31.96%24.33M
9.59%30.34M
Total equity
631.99%198.61M
519.78%206.75M
602.59%182.69M
-47.81%18.10M
-16.77%27.13M
-18.83%33.36M
-37.66%26.00M
-36.88%34.68M
-53.65%32.60M
-50.28%41.10M
-59.27%41.71M
-55.68%54.95M
-52.09%70.33M
-51.07%82.66M
-54.42%102.40M
-46.51%123.98M
-40.63%146.79M
-29.78%168.93M
-16.97%224.65M
-13.22%231.79M
Net operating income
5.73%-22.10M
3598.03%14.24M
0.73%-15.13M
2.01%-16.76M
-27.64%-23.44M
-100.55%-407.00K
-10.08%-15.24M
-25.49%-17.10M
21.62%-18.36M
482.50%73.65M
30.14%-13.85M
23.80%-13.63M
14.81%-23.43M
0.56%-19.25M
-4.98%-19.82M
17.99%-17.89M
17.52%-27.50M
23.38%-19.36M
-277.36%-18.88M
5.66%-21.81M
Net investment
-181.72%-5.38M
416.95%21.22M
-746.32%-158.27M
232.76%16.99M
-61.87%6.59M
92.53%-6.70M
29.70%24.49M
161.05%5.11M
72.72%17.27M
-641.32%-89.65M
-39.93%18.88M
-187.16%-8.37M
-69.74%10.00M
295.21%16.56M
56.61%31.43M
410.88%9.60M
83.44%33.05M
-140.96%-8.48M
140.23%20.07M
-104.03%-3.09M
Net financing
-92.25%149.00K
-97.32%456.00K
--171.93M
-97.13%357.00K
--1.92M
84.89%17.00M
--0.00
9194.03%12.45M
-100.00%0.00
2003.43%9.19M
--0.00
-24.29%134.00K
--4.49M
-83.89%437.00K
-100.00%0.00
-97.13%177.00K
-100.00%0.00
-52.29%2.71M
1092.76%10.05M
548.32%6.16M

FAQs

What is the total revenue of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its total revenue reached 72.30M, with a year-on-year change of 28.52M.

What are the current assets of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its current assets were 254.55M, with a year-on-year change of 120.38.

What are the total assets of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its total assets of Assembly Biosciences Inc were 257.59M, with a year-on-year change of 116.16.

What are the total liabilities of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its total liabilities of Assembly Biosciences Inc were 50.84M, with a year-on-year change of -40.75.

What is the total equity of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its total equity of Assembly Biosciences Inc was 206.75M, with a year-on-year change of 519.78.

What is the net operating income of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its net operating income of Assembly Biosciences Inc was -12.12M, with a year-on-year change of 73.32.

What is the net investment of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its net investment of Assembly Biosciences Inc was -113.47M, with a year-on-year change of -382.46.

What is the net financing of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its net financing of Assembly Biosciences Inc was 174.67M, with a year-on-year change of 493.12.

What is the Earnings Per Share (EPS) of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.55, with a year-on-year change of 91.84.

What is the net income of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its net income was -6.12M, with a year-on-year change of 84.76.

What is the net margin of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its net profit margin was -8.47, with a year-on-year change of 93.99.

What is the Return on Equity (ROE) of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -5.10, with a year-on-year change of 95.27.

What is the Return on Assets (ROA) of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -3.25, with a year-on-year change of 89.65.

What is the operating profit of Assembly Biosciences Inc?

According to Assembly Biosciences Inc's FY2025 earnings report, its operating profit was -12.12M, with a year-on-year change of 73.32.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.